This meeting will bring together researchers, pharma industry experts and regulatory bodies to discuss the challenges and drivers of 3D cell culture through case studies of innovative technologies and real world clinical applications. Delegates will also gain insights into the regulatory validation of the new technologies. There will also be discussion of high throughput screening.
